Andere talen Kyowa Kirin Co., Ltd. OTC Markets

Aandelen

KYKOY

US50156R1077

Vertraagde tijd OTC Markets Andere beurzen 15:50:18 16-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
19,85 ^USD	+0,27%		0,00%	+22,18%

03/07	Kyowa Kirin koopt aandelen terug	MT
07/05	Winst Kyowa Kirin 15% hoger in Q1	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Kyowa Kirin Buys Back Shares	03/07
Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	02/07
Kyowa Kirin : Announces Application for Additional Formulation of “LUMICEF® Subcutaneous Injection 210 mg Pen” in Japan	28/06
Kyowa Kirin Repurchases 3.3 Million Shares in May	05/06
Kyowa Kirin : Announces Approval for Partial Change of Approved Indication of G-Lasta® for the Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Blood Stem Cell Transplantation in Japan (243KB)	17/05
Kyowa Kirin : Transcript of Results Briefing Fiscal 2024 First Quarter (0B)	09/05
Kyowa Kirin's Profit Up 15% in Q1	07/05
Kyowa Kirin : Results Presentation Fiscal 2024 First Quarter (0B)	07/05
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List	06/05
Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April	06/05
BridgeBio Pharma Shares Decline After Q1 Financial Results	02/05
Kyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ (istradefylline) and Other Parkinson's Disease Add-On Therapies	15/04
First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome	15/04
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease	08/04
Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March	03/04
Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	02/04
Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed	25/03
Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation	25/03
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag	20/03
EEUU aprueba la primera terapia de genes para niños con una rara enfermedad hereditaria	18/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Kyowa Kirin Co., Ltd. OTC Markets

Aandelen

KYKOY

US50156R1077

Andere talen

Filters